Brain Shuttle Neprilysin reduces central Amyloid-β levels

Reducing Amyloid β (Aβ) in the brain is of fundamental importance for advancing the therapeutics for Alzheimer`s disease. The endogenous metallopeptidase neprilysin (NEP) has been identified as one of the key Aβ-degrading enzymes. Delivery of NEP to the brain by utilizing the Brain Shuttle (BS) tran...

Descripción completa

Detalles Bibliográficos
Autores principales: Campos, Christopher R., Kemble, Alicia M., Niewoehner, Jens, Freskgård, Per-Ola, Urich, Eduard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7064168/
https://www.ncbi.nlm.nih.gov/pubmed/32155191
http://dx.doi.org/10.1371/journal.pone.0229850

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7064168/
https://www.ncbi.nlm.nih.gov/pubmed/32155191
http://dx.doi.org/10.1371/journal.pone.0229850

Ejemplares similares